Impact of vitamin D receptor gene polymorphisms (TaqI and BsmI) on the incidence and severity of coronary artery disease: a report from southern Iran

[1]  S. Heydari,et al.  Association between Fok1 and TaqI polymorphisms of vitamin D receptor gene with the severity of stenosis and calcification in carotid bulb in patients with ischemic stroke , 2022, Journal of Clinical Neuroscience.

[2]  S. Saleem,et al.  Vitamin D receptor gene polymorphism TaqI (rs731236) and its association with the susceptibility to coronary artery disease among Pakistani population , 2021, The journal of gene medicine.

[3]  N. Samy,et al.  Vitamin D levels and vitamin D receptor genetic variants in Egyptian cardiovascular disease patients with and without diabetes , 2021, Egyptian Journal of Medical Human Genetics.

[4]  F. Foroughinia,et al.  The association between estrogen receptor 2 gene polymorphism and complexity of coronary artery disease: an analysis in elective percutaneous coronary intervention patients , 2021, BMC Cardiovascular Disorders.

[5]  S. Kraljević Pavelić,et al.  Study of vitamin D receptor gene polymorphisms in a cohort of myocardial infarction patients with coronary artery disease , 2021, BMC Cardiovascular Disorders.

[6]  A. Norouzy,et al.  Vitamin D supplementation effects on the clinical outcomes of patients with coronary artery disease: a systematic review and meta-analysis , 2020, Scientific Reports.

[7]  Yiyi Zhang,et al.  Vitamin D for inflammation biomarkers in coronary artery disease: a protocol for systematic review and meta-analysis , 2020 .

[8]  F. Foroughinia,et al.  Genotype and allele frequencies of two Vitamin-D receptor gene polymorphisms (ApaI and BsmI) in patients undergoing elective percutaneous coronary intervention in Iranian population , 2020 .

[9]  E. Chouery,et al.  FokI vitamin D receptor gene polymorphism and serum 25-hydroxyvitamin D in patients with cardiovascular risk , 2019, Archives of medical sciences. Atherosclerotic diseases.

[10]  D. Grimm,et al.  Potential Beneficial Effects of Vitamin D in Coronary Artery Disease , 2019, Nutrients.

[11]  H-L Yi,et al.  The association between vitamin D receptor gene polymorphism and susceptibility to hypertension: a meta-analysis. , 2019, European review for medical and pharmacological sciences.

[12]  Z. Rahimi,et al.  Vitamin D-binding protein and vitamin D receptor genotypes and 25-hydroxyvitamin D levels are associated with development of aortic and mitral valve calcification and coronary artery diseases , 2019, Molecular Biology Reports.

[13]  S. Jain,et al.  Serum Vitamin D Level in Patients with Coronary Artery Disease and Association with Sun Exposure: Experience from a Tertiary Care, Teaching Hospital in India , 2019, Advances in medicine.

[14]  D. Liew,et al.  Risk stratification for coronary artery disease in multi-ethnic populations: Are there broader considerations for cost efficiency? , 2019, World journal of methodology.

[15]  Ameen M Mohammad,et al.  Vitamin D status in acute myocardial infarction: a case–control study , 2018, Cardiovascular endocrinology & metabolism.

[16]  V. Kyriazopoulou,et al.  Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis , 2018, Scientific Reports.

[17]  J. Kojuri,et al.  Impact of Omega-3 Supplementation on High Sensitive C-Reactive Protein Level and 30-Day Major Adverse Cardiac Events After the Implementation of Coronary Stent in Patients with Chronic Kidney Disease: A Randomized Clinical Study , 2018, Advanced pharmaceutical bulletin.

[18]  N. Mirhosseini,et al.  Vitamin D Supplementation, Serum 25(OH)D Concentrations and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis , 2018, Front. Cardiovasc. Med..

[19]  M. Moradi,et al.  Evaluation of vitamin D levels in relation to coronary CT angiographic findings in an Iranian population , 2017, Vascular health and risk management.

[20]  K. Djafarian,et al.  Common Variants of Vitamin D Receptor Gene Polymorphisms and Susceptibility to Coronary Artery Disease: A Systematic Review and Meta-Analysis , 2017, Lifestyle Genomics.

[21]  M. Gad,et al.  Vitamin D receptor gene polymorphisms (TaqI and ApaI) in relation to 25-hydroxyvitamin D levels and coronary artery disease incidence , 2015, Journal of receptor and signal transduction research.

[22]  H. Huikuri,et al.  Serum 25-hydroxyvitamin D is associated with major cardiovascular risk factors and cardiac structure and function in patients with coronary artery disease. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[23]  Menghong Wang,et al.  Association of vitamin d receptor-a gene polymorphisms with coronary heart disease in Han Chinese. , 2015, International journal of clinical and experimental medicine.

[24]  Francisco das Chagas Monteiro Júnior,et al.  Is Vitamin D Deficiency a New Risk Factor for Cardiovascular Disease? , 2015, The open cardiovascular medicine journal.

[25]  R. Christopher,et al.  Genetic variants of vitamin D receptor and susceptibility to ischemic stroke. , 2015, Biochemical and biophysical research communications.

[26]  E. Bahramali,et al.  Renin–angiotensin system genetic polymorphisms: Lack of association with CRP levels in patients with coronary artery disease , 2014, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[27]  K. Mirzaei,et al.  The Role of Vitamin D Deficiency and Vitamin D Receptor Genotypes on the Degree of Collateralization in Patients with Suspected Coronary Artery Disease , 2014, BioMed research international.

[28]  J. Manson,et al.  Vitamin D deficiency and coronary artery disease: a review of the evidence. , 2014, American heart journal.

[29]  H. Bakhshandeh,et al.  Gender specificity of a genetic variant of angiotensin-converting enzyme and risk of coronary artery disease , 2013, Molecular Biology Reports.

[30]  M. Marre,et al.  Allelic variations of the vitamin D receptor (VDR) gene are associated with increased risk of coronary artery disease in type 2 diabetics: the DIABHYCAR prospective study. , 2013, Diabetes & metabolism.

[31]  H. Bakhshandeh,et al.  Association of angiotensin-converting enzyme polymorphism with coronary artery disease in Iranian patients with unipolar depression. , 2012, Clinical biochemistry.

[32]  J. Manson,et al.  Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies , 2012, Circulation. Cardiovascular quality and outcomes.

[33]  E. Onrat,et al.  Prevalence of myocardial infarction polymorphisms in Afyonkarahisar, Western Turkey , 2012, Molecular Biology Reports.

[34]  W. März,et al.  Vitamin D, cardiovascular disease and mortality , 2011, Clinical endocrinology.

[35]  A. Majluf-Cruz,et al.  C677T polymorphism of the 5,10 MTHFR gene in young Mexican subjects with ST-elevation myocardial infarction. , 2010, Archives of medical research.

[36]  Tian-Yi Chen,et al.  No association between vitamin D receptor polymorphisms and coronary artery disease in a Chinese population. , 2009, DNA and cell biology.

[37]  Sara Gandini,et al.  Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. , 2009, Carcinogenesis.

[38]  Alíz Kunstár,et al.  Methylentetrahydrofolate Reductase and Nitric Oxide Synthase Polymorphism in Patients with Atherosclerosis and Diabetes , 2009, Pathology & Oncology Research.

[39]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[40]  G. Targher,et al.  Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. , 2006, Diabetes care.

[41]  R. Koerfer,et al.  Putting cardiovascular disease and vitamin D insufficiency into perspective , 2005, British Journal of Nutrition.

[42]  K. Zerres,et al.  Vitamin D receptor gene polymorphism BsmI is not associated with the prevalence and severity of CAD in a large‐scale angiographic cohort of 3441 patients , 2003, European journal of clinical investigation.

[43]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[44]  R. Hoffmann,et al.  The vitamin D receptor gene variant is associated with the prevalence of Type 2 diabetes mellitus and coronary artery disease , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[45]  M. Chatterjee,et al.  Vitamin D and genomic stability. , 2001, Mutation research.

[46]  H. Minne,et al.  Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. , 2001, The Journal of clinical endocrinology and metabolism.

[47]  S. Moore,et al.  Pathogenesis of atherosclerosis. , 1985, Metabolism: clinical and experimental.

[48]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[49]  F. Foroughinia,et al.  Association between Serum Vitamin D Concentration Status and Matrix Metalloproteinase-9 in Patients Undergoing Elective Percutaneous Coronary Intervention , 2020, Iranian journal of pharmaceutical research : IJPR.

[50]  L. Cerit,et al.  Vitamin D Deficiency is not Associated with Higher Levels of SYNTAX Score , 2019, Brazilian journal of cardiovascular surgery.

[51]  C. Bauters,et al.  [Pathophysiology of coronary artery disease]. , 2008, La Revue du praticien.

[52]  G. Targher,et al.  Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. , 2006, Diabetes care.

[53]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..